These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 33819672)
1. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials. Verdoia M; Negro F; Kedhi E; Suryapranata H; Marcolongo M; De Luca G Vascul Pharmacol; 2021 Jun; 138():106859. PubMed ID: 33819672 [TBL] [Abstract][Full Text] [Related]
2. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design. Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review. Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010 [TBL] [Abstract][Full Text] [Related]
4. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials. Sedhom R; Hamed M; Elbadawi A; Mohsen A; Swamy P; Athar A; Bharadwaj AS; Prasad V; Elgendy IY; Alfonso F JACC Cardiovasc Interv; 2024 Jul; 17(13):1533-1543. PubMed ID: 38986653 [TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease. Abdoli S; Mert M; Lee WM; Ochoa CJ; Katz SG J Vasc Surg; 2021 May; 73(5):1802-1810.e4. PubMed ID: 33249205 [TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloons: Technical and clinical progress. Ang H; Koppara TR; Cassese S; Ng J; Joner M; Foin N Vasc Med; 2020 Dec; 25(6):577-587. PubMed ID: 32634046 [TBL] [Abstract][Full Text] [Related]
7. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials. Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486 [TBL] [Abstract][Full Text] [Related]
9. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials. Anantha-Narayanan M; Shah SM; Jelani QU; Garcia S; Ionescu C; Regan C; Mena-Hurtado C Catheter Cardiovasc Interv; 2019 Jul; 94(1):139-148. PubMed ID: 30838719 [TBL] [Abstract][Full Text] [Related]
10. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274 [TBL] [Abstract][Full Text] [Related]
11. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769 [TBL] [Abstract][Full Text] [Related]
12. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis. Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study. Uskela S; Kärkkäinen JM; Eränen J; Siljander A; Mäntylä P; Mustonen J; Rissanen TT Catheter Cardiovasc Interv; 2019 Apr; 93(5):893-900. PubMed ID: 30380186 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718 [TBL] [Abstract][Full Text] [Related]
15. Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials. Liu W; Zhang M; Chen G; Li Z; Wei F Cardiovasc Ther; 2020; 2020():4158363. PubMed ID: 32934664 [TBL] [Abstract][Full Text] [Related]
16. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial. Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939 [TBL] [Abstract][Full Text] [Related]
17. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518 [TBL] [Abstract][Full Text] [Related]
18. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Megaly M; Ali A; Abraham B; Khalil C; Zordok M; Shaker M; Tawadros M; Hennawy BS; Elbadawi A; Omer M; Saad M Cardiovasc Revasc Med; 2020 Jan; 21(1):78-85. PubMed ID: 30956042 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE). Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096 [TBL] [Abstract][Full Text] [Related]
20. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]